BioCentury | Dec 19, 2020
Product Development

Dec. 18 Quick Takes: FDA approves expanded label for Benlysta and first oral prostate cancer therapy; plus Novartis, FibroGen, A2i, China’s NRDL and more

...the Israeli Innovation Authority, was founded via a JV among Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures...
BioCentury | Dec 16, 2020
Deals

Dec. 15 Quick Takes: Singlera raises $150M for cancer dx; plus AnGes-Emendo, Entresto, vTv and Unity

...operations in New York City and Tel Aviv, was founded in 2015 by OrbiMed and Takeda Ventures.FDA...
BioCentury | Nov 23, 2020
Emerging Company Profile

SV Health-incubated Catamaran debuts with $42M to develop CAR NK pipeline

...Partners and Lightstone Ventures led the A round, which also saw participation from SV Health, Takeda Ventures...
...partners: NoneNumber of employees: 16Funds raised: $42 millionInvestors: Sofinnova Partners, Lightstone  Ventures, SV Health Investors, Takeda Ventures...
BioCentury | Nov 5, 2020
Deals

Merck adds ROR1 to its pipeline, rewards VelosBio’s investors with $2.8B takeout

...for $21 billion.Arix and Sofinnova Ventures co-led VelosBio’s series A round, investing alongside Pappas, Chiesi Ventures, Takeda Ventures...
BioCentury | Oct 23, 2020
Emerging Company Profile

Be Bio: bringing the B to cell therapy

...like the T cell therapy landscape.”Also participating in the series A round were Alta Partners and Takeda Ventures. Be...
BioCentury | Oct 17, 2020
Finance

Novartis Venture Fund’s move to earlier, riskier bets starting to pay off

...and Michal Silverberg, former senior partner at Takeda Ventures...
BioCentury | Sep 18, 2020
Finance

With details on lead sialoglycan degrader in place, Palleon raises $100M series B

...SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures...
BioCentury | Jul 22, 2020
Finance

Shonan iPark venture consortium seeks to boost bets on Japanese biotechs

...information-gathering and pitch events, and joint nurturing of entrepreneurial talent. Shonan Health Innovation Park named Takeda Ventures...
...dispersed offices looking for a central location, Fujimoto said. Karen Tkach Tuzman, Associate Editor Takeda Pharmaceutical Co. Ltd. Takeda Ventures...
BioCentury | Jul 8, 2020
Finance

VelosBio jumps on megaround bandwagon with $137M series B

...well as existing investors Arix Bioscience plc (LSE:ARIX), Decheng Capital, Pappas Capital, Sofinnova Ventures and Takeda Ventures...
BioCentury | Jul 1, 2020
Emerging Company Profile

With potential for re-dosing, Carmine’s gene therapy tech attracts Takeda as partner

...loan, bringing Carmine’s total funding to $9.4 million. The biotech has also received funding from Takeda Ventures...
Items per page:
1 - 10 of 100
BioCentury | Dec 19, 2020
Product Development

Dec. 18 Quick Takes: FDA approves expanded label for Benlysta and first oral prostate cancer therapy; plus Novartis, FibroGen, A2i, China’s NRDL and more

...the Israeli Innovation Authority, was founded via a JV among Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures...
BioCentury | Dec 16, 2020
Deals

Dec. 15 Quick Takes: Singlera raises $150M for cancer dx; plus AnGes-Emendo, Entresto, vTv and Unity

...operations in New York City and Tel Aviv, was founded in 2015 by OrbiMed and Takeda Ventures.FDA...
BioCentury | Nov 23, 2020
Emerging Company Profile

SV Health-incubated Catamaran debuts with $42M to develop CAR NK pipeline

...Partners and Lightstone Ventures led the A round, which also saw participation from SV Health, Takeda Ventures...
...partners: NoneNumber of employees: 16Funds raised: $42 millionInvestors: Sofinnova Partners, Lightstone  Ventures, SV Health Investors, Takeda Ventures...
BioCentury | Nov 5, 2020
Deals

Merck adds ROR1 to its pipeline, rewards VelosBio’s investors with $2.8B takeout

...for $21 billion.Arix and Sofinnova Ventures co-led VelosBio’s series A round, investing alongside Pappas, Chiesi Ventures, Takeda Ventures...
BioCentury | Oct 23, 2020
Emerging Company Profile

Be Bio: bringing the B to cell therapy

...like the T cell therapy landscape.”Also participating in the series A round were Alta Partners and Takeda Ventures. Be...
BioCentury | Oct 17, 2020
Finance

Novartis Venture Fund’s move to earlier, riskier bets starting to pay off

...and Michal Silverberg, former senior partner at Takeda Ventures...
BioCentury | Sep 18, 2020
Finance

With details on lead sialoglycan degrader in place, Palleon raises $100M series B

...SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures...
BioCentury | Jul 22, 2020
Finance

Shonan iPark venture consortium seeks to boost bets on Japanese biotechs

...information-gathering and pitch events, and joint nurturing of entrepreneurial talent. Shonan Health Innovation Park named Takeda Ventures...
...dispersed offices looking for a central location, Fujimoto said. Karen Tkach Tuzman, Associate Editor Takeda Pharmaceutical Co. Ltd. Takeda Ventures...
BioCentury | Jul 8, 2020
Finance

VelosBio jumps on megaround bandwagon with $137M series B

...well as existing investors Arix Bioscience plc (LSE:ARIX), Decheng Capital, Pappas Capital, Sofinnova Ventures and Takeda Ventures...
BioCentury | Jul 1, 2020
Emerging Company Profile

With potential for re-dosing, Carmine’s gene therapy tech attracts Takeda as partner

...loan, bringing Carmine’s total funding to $9.4 million. The biotech has also received funding from Takeda Ventures...
Items per page:
1 - 10 of 100